Geode Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
|
|||||
|
2025
Q1 | $9.31M | Buy |
|
|||||
|
2024
Q4 | $12.2M | Buy |
|
|||||
|
2024
Q3 | $15.1M | Sell |
|
|||||
|
2024
Q2 | $16.3M | Buy |
|
|||||
|
2024
Q1 | $1.76M | Buy |
|
|||||
|
2023
Q4 | $1.31M | Sell |
|
|||||
|
2023
Q3 | $972K | Buy |
|
|||||
|
2023
Q2 | $1.33M | Buy |
|
|||||
|
2023
Q1 | $733K | Buy |
|
|||||
|
2022
Q4 | $566K | Buy |
|
|||||
|
2022
Q3 | $203K | Hold |
|
|||||
|
2022
Q2 | $98K | Hold |
|
|||||
|
2022
Q1 | $276K | Hold |
|
|||||
|
2021
Q4 | $327K | Hold |
|
|||||
|
2021
Q3 | $397K | Hold |
|
|||||
|
2021
Q2 | $272K | Sell |
|
|||||
|
2021
Q1 | $383K | Buy |
|
|||||
|
2020
Q4 | $230K | Hold |
|
|||||
|
2020
Q3 | $174K | Buy |
|
|||||
|
2020
Q2 | $221K | Buy |
|
|||||
|
2020
Q1 | $207K | Sell |
|
|||||
|
2019
Q4 | $348K | Hold |
|
|||||
|
2019
Q3 | $192K | Hold |
|
|||||
|
2019
Q2 | $133K | Buy |
|
|||||
|
2019
Q1 | $53K | Hold |
|
|||||
|
2018
Q4 | $95K | Hold |
|
|||||
|
2018
Q3 | $162K | Hold |
|
|||||
|
2018
Q2 | $226K | Buy |
|
|||||
|
2018
Q1 | $92K | Hold |
|
|||||
|
2017
Q4 | $103K | Sell |
|
|||||
|
2017
Q3 | $231K | Sell |
|
|||||
|
2017
Q2 | $367K | Buy |
|
|||||
|
2017
Q1 | $302K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $275K | Sell |
|
|||||
|
2016
Q2 | $280K | Buy |
|
|||||
|
2016
Q1 | $164 | Sell |
|
|||||
|
2015
Q4 | $183K | Buy |
|
|||||
|
2015
Q3 | $217K | Sell |
|
|||||
|
2015
Q2 | $293K | Buy |
|
|||||
|
2015
Q1 | $225K | Buy |
|
|||||
|
2014
Q4 | $203K | Buy |
|